In November 2018, KALY acquired NCM Biotech (CBD extraction patent + CBD clinical trials)
Also in November 2018, old KALY CEO Charles Yawn, stepped down, and NCM Biotech CEO Frederick Ferri took over
The current company KALY has nothing to do with anything related to VLOV or Charles Yawn and everything to do with NCM Biotech's CEO, advisory board, CBD patent and CBD clinical trials for COPD (and others.)
In order to not dilute, KALY is in the process of manufacturing CBD gummies, oils, beverages, etc. to build a revenue stream before the CBD franchising that involves there patent (model currently underway with NOUV and 100 acre facility) begins in February and also they will continue providing 10mg and 25mg CBD for various drinks under contract with PURA